scientific Sessions

Pharmacovigilance in Cell and Gene Therapy

The goal of pharmacovigilance is to spot, assess, comprehend, and avoid side effects or any other issues related to prescriptions. Because gene and cell therapies are novel treatments that may present unanticipated dangers to patient safety and public health, pharmacovigilance is crucial. ATMP developers are urged to make rapid appointments with EMA to guarantee a successful development process.

Related Sessions

Innovations in Gene Editing
The Cell Therapy in Cancer Treatment
Ethical Considerations in Germline Gene Editing
Stem Cell Therapy: From Bench to Bedside
Ex Vivo Gene Editing: Techniques, Applications, and Challenges
Manufacturing Challenges in Cell and Gene Therapy
Clinical Trials and Real World Applications of Gene Therapy
Overcoming Challenges in AAV Based Gene Therapy
Ethical Considerations in Genetic Engineering and Therapy
Gene Therapy for Neurodegenerative Diseases
Advancements in Non Viral Gene Delivery Systems
Cell Therapy Manufacturing: Overcoming Scalability Issues
Gene Editing for Haematological Disorders
Future Trends: AI and Machine Learning in Cell and Gene Therapy Development
Immune System Modulation and Cell Therapy: Balancing Efficacy and Safety
Longitudinal Studies of Cell and Gene Therapy Outcomes
Non Viral Gene Delivery Strategies
Pharmacovigilance in Cell and Gene Therapy
Advances in CAR T Cell Therapies
Manufacturing and Process Analytics in Cell and Gene Therapy
Gene Editing for Haematological Disorders
Hematopoietic Stem Cell based Cell and Gene Therapy
Data Integrity and Clinical Trial Design in Cell and Gene Therapy
Next Generation Gene Therapy
Regulatory Landscape for Cell and Gene Therapies: Global Perspectives
Targeting Rare Genetic Diseases with Gene Therapy
In Vivo Gene Therapy: Current Approaches and Future Directions
Ethics of Gene Therapy in Children and Vulnerable Populations
Ethical Implications of Using Gene Therapy for Non Lethal Conditions
Don't miss our future updates!

Get in Touch